Literature DB >> 7770116

The cortical neuritic pathology of Huntington's disease.

M Jackson1, S Gentleman, G Lennox, L Ward, T Gray, K Randall, K Morrell, J Lowe.   

Abstract

We have studied the brains of 10 patients with clinically and pathologically defined Huntington's disease and graded the degree of striatal pathology according to the Vonsattel grading system. Sections from nine cerebral cortical areas (Brodmann areas 8, 10, 24, 33, 28, 38, 7, 39, 18), the cerebellum, hypothalamus, medulla and caudate nucleus were stained with antibodies to ubiquitin and ubiquitin C-terminal hydrolase (PGP 9.5). Dystrophic neurites, immunoreactive with ubiquitin and PGP 9.5 were detected in all cortical areas, in layers 3, 5 and 6, of all brains studied. No dystrophic neurites were found in subcortical areas or cerebellum. Sections from cortical areas 8 and 24 from the two brains with the most and least ubiquitin-immunoreactive neurites were stained with antibodies to beta-amyloid precursor protein, tau, glial fibrillary acidic protein, neurofilament protein, alpha B crystallin, GABA, cholecystokinin and somatostatin. The dystrophic neurites were found to also react with beta-amyloid precursor protein. Electron microscopy showed the abnormal neurites to contain granulofilamentous material. Granular deposits with a diameter of 40-100 nm were interspersed between randomly orientated 'fuzzy' or coated, straight or slightly curved filaments measuring 10-15 nm in diameter. These structures have not been seen in control brain and differ from age-related neuritic degeneration and neurites associated with amyloid. Immunohistochemically these structures most resemble CA 2/3 neurites seen in Lewy body disease, and, ultrastructurally, the intraneuronal filamentous inclusions in motor neuron disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7770116     DOI: 10.1111/j.1365-2990.1995.tb01024.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  13 in total

1.  Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.

Authors:  H Diana Rosas; David H Salat; Stephanie Y Lee; Alexandra K Zaleta; Vasanth Pappu; Bruce Fischl; Doug Greve; Nathanael Hevelone; Steven M Hersch
Journal:  Brain       Date:  2008-03-12       Impact factor: 13.501

2.  Neuritic regeneration and synaptic reconstruction induced by withanolide A.

Authors:  Tomoharu Kuboyama; Chihiro Tohda; Katsuko Komatsu
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

3.  Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer's Disease.

Authors:  Liu He; Yuqi Jiang; Kai Liu; Victoria Gomez-Murcia; Xiaopin Ma; Alejandro Torrecillas; Qun Chen; Xiongwei Zhu; Edward Lesnefsky; Juan C Gomez-Fernandez; Bin Xu; Shijun Zhang
Journal:  J Med Chem       Date:  2018-01-05       Impact factor: 7.446

Review 4.  Are there multiple pathways in the pathogenesis of Huntington's disease?

Authors:  N Aronin; M Kim; G Laforet; M DiFiglia
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

5.  Analysis of YFP(J16)-R6/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington's disease.

Authors:  Rodolfo G Gatto; Yaping Chu; Allen Q Ye; Steven D Price; Ehsan Tavassoli; Andrea Buenaventura; Scott T Brady; Richard L Magin; Jeffrey H Kordower; Gerardo A Morfini
Journal:  Hum Mol Genet       Date:  2015-06-29       Impact factor: 6.150

6.  Promotion of axonal maturation and prevention of memory loss in mice by extracts of Astragalus mongholicus.

Authors:  C Tohda; T Tamura; S Matsuyama; K Komatsu
Journal:  Br J Pharmacol       Date:  2006-09-18       Impact factor: 8.739

7.  Mapping the order and pattern of brain structural MRI changes using change-point analysis in premanifest Huntington's disease.

Authors:  Dan Wu; Andreia V Faria; Laurent Younes; Susumu Mori; Timothy Brown; Hans Johnson; Jane S Paulsen; Christopher A Ross; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2017-06-28       Impact factor: 5.038

8.  Pathoarchitectonics of the cerebral cortex in chorea-acanthocytosis and Huntington's disease.

Authors:  J Liu; H Heinsen; L T Grinberg; E Alho; E Amaro; C A Pasqualucci; U Rüb; K Seidel; W den Dunnen; T Arzberger; C Schmitz; M C Kiessling; B Bader; A Danek
Journal:  Neuropathol Appl Neurobiol       Date:  2018-06-10       Impact factor: 8.090

9.  Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis.

Authors:  Kristina Becanovic; Mahmoud A Pouladi; Raymond S Lim; Alexandre Kuhn; Paul Pavlidis; Ruth Luthi-Carter; Michael R Hayden; Blair R Leavitt
Journal:  Hum Mol Genet       Date:  2010-01-20       Impact factor: 6.150

Review 10.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

Authors:  Robert Schwarcz; Paolo Guidetti; Korrapati V Sathyasaikumar; Paul J Muchowski
Journal:  Prog Neurobiol       Date:  2009-04-24       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.